UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(D) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): ~~April~~June 2024, 2005

GlycoGenesys, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Nevada

(State or Other Jurisdiction of Incorporation)

0-26476		33-0231238
(Commission File Number)		(IRS Employer Identification No.)
31 St. James Avenue, Boston, Massachusetts		02116
(Address of Principal Executive Offices)		(Zip Code)

31 St. James Avenue, Boston, Massachusetts		02116
(Address of Principal Executive Offices)		(Zip Code)

(617) 422-0674

(Registrant’s Telephone Number, Including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 35.0103 – ~~Notice~~Amendments ~~of Delisting or Failure~~ to ~~Satisfy~~Articles aof ~~Continued~~Incorporation ~~Listing Rule~~ or ~~Standard~~Bylaws; ~~Transfer~~Change ofin ~~Listing~~ Fiscal Year

On ~~April~~June 2024, 2005, GlycoGenesys, Inc. (the “Company”) ~~received~~filed a ~~letter~~ ~~from~~Certificate of Amendment (the ~~Nasdaq~~“Certificate”) ~~Stock~~to ~~Market~~its ~~indicating~~Articles ~~that~~of ~~the~~Incorporation ~~Company does not comply~~ with the ~~minimum~~Nevada ~~bid~~Secretary ~~price~~of ~~requirement~~State ~~for~~which ~~continued~~was ~~listing~~effective ~~set~~upon ~~forth in Nasdaq Marketplace Rule 4310(c)(4) (the “Bid Price Requirement”)~~filing. The ~~Company~~Certificate ~~has~~amended ~~a 180~~Article ~~day~~Fourth ~~period~~of ~~ending on October 17, 2005 to regain compliance with~~ the ~~Bid Price Requirement. If the~~ Company’s ~~closing~~Articles ~~bid price is at least $1.00 for a period~~ of atIncorporation ~~least~~to 10increase ~~consecutive trading days,~~ the ~~Company will have regained compliance~~ ~~with~~number ~~the~~of ~~Bid~~authorized ~~Price~~shares ~~Requirement.~~of Ifcommon ~~the~~stock ~~Company~~from ~~has not regained compliance with the Bid Price Requirement by October 17~~33, ~~2005~~333,333 ~~it will have an additional 180 day period~~ to ~~regain compliance ending on April 15~~75,000,000. ~~2006~~The iftotal ~~the~~number ~~Company~~of ~~satisfies~~authorized ~~initial listing~~preferred ~~requirements~~shares ~~(other~~remains ~~than~~unchanged ~~the~~at ~~Bid~~5,000,000 ~~Price~~shares, ~~Requirement)~~thus ~~for~~ the ~~Nasdaq SmallCap Market. The~~ Company’s ~~stock~~total ~~will~~number ~~not be delisted from the Nasdaq SmallCap Market because~~ of ~~its~~authorized ~~failure~~shares towas ~~comply~~increased ~~with~~from ~~the Bid Price Requirement during such 180~~38,333,333 orto ~~360 day period~~80, ~~as applicable~~000,000.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 26, 2005	By:	/s/ Bradley J Carver
Dated: June 30, 2005	By:	/s/ Bradley J Carver
		Bradley J Carver
		Chief Executive Officer and President
		President and Chief Executive Officer

Filing Compare · GLYCOGENESYS INC